MedTrace Logo

Efficacy and Safety of a Purified Standardised Wasp Venom Preparation

NCT00263926 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2013-03-11

No results posted yet for this study

Summary

The trial is performed to assess efficacy and safety of a purified standardised wasp venom preparation in wasp venom allergy

Conditions

  • Allergy

Interventions

BIOLOGICAL

wasp venom

Sponsors & Collaborators

  • Allergopharma GmbH & Co. KG

    lead INDUSTRY

Principal Investigators

  • Annemie Narkus, M.D.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-03-31
Primary Completion
2007-05-31
Completion
2010-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00263926 on ClinicalTrials.gov